Active Ingredient(s): Mecasermin Recombinant
FDA Approved: * August 30, 2005
Pharm Company: * TERCICA
Category: Growth Hormone Treatment

Mecasermin (INN) (brand name Increlex), also known as recombinant human insulin-like growth factor-1 (rhIGF-1), is a recombinant form of human insulin-like growth factor 1 (IGF-I) which is used in the long-term treatment of growth failure and short stature in children with severe primary IGF-I deficiency, for instance due to growth hormone deficiency or Laron syndrome (growth hormone insensitivity).[1][2][3] Mecasermin has a biological half-life... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Increlex 40 mg/4ml Subcutaneous Injection, Solution
NDC: 15054-1040
Ipsen Biopharmaceuticals, Inc.

Related Brands

Drugs with the same active ingredients